Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Valproate semisodium |
Is a |
False |
Valproate |
Inferred relationship |
Some |
|
Fetal valproate syndrome |
Causative agent (attribute) |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate blood measurement |
Component |
False |
Valproate |
Inferred relationship |
Some |
|
Serum sodium valproate measurement (procedure) |
Component |
False |
Valproate |
Inferred relationship |
Some |
|
Allergy to valproate sodium |
Causative agent (attribute) |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate 200 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate 500 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate 300mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate 100mg crushable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate 200mg/5mL s/f oral liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate 200mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Product containing valproate sodium in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Oral form sodium valproate m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Valproic acid (substance) |
Is a |
False |
Valproate |
Inferred relationship |
Some |
|
Product containing valproate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Valproic acid measurement |
Component |
False |
Valproate |
Inferred relationship |
Some |
|
Sodium valproate |
Is a |
False |
Valproate |
Inferred relationship |
Some |
|
Valproic acid 150 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Product containing valproic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproate |
Inferred relationship |
Some |
|
Allergy to valproate sodium |
Causative agent (attribute) |
False |
Valproate |
Inferred relationship |
Some |
1 |